Company Protagenic Therapeutics, Inc. Other OTC
Equities
PTIX
US74365N1037
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alexander Arrow
DFI | Director of Finance/CFO | 53 | 16-01-31 |
Andrew Slee
COO | Chief Operating Officer | 74 | 16-01-31 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 16-02-11 |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Garo Armen
FOU | Founder | 71 | 94-02-02 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 16-02-11 |
Brian Corvese
BRD | Director/Board Member | 67 | 17-07-27 |
Khalil Barrage
BRD | Director/Board Member | 59 | 07-06-30 |
Timothy Wright
BRD | Director/Board Member | 66 | 22-11-22 |
Jennifer Buell
BRD | Director/Board Member | 50 | 20-07-17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,435,132 | 3,466,915 ( 78.17 %) | 0 | 78.17 % |
Company contact information
Protagenic Therapeutics, Inc.
149 Fifth Avenue Suite 500
10010, New York
+212 994 8200
http://www.protagenic.comSector
1st Jan change | Capi. | |
---|---|---|
+64.92% | 62.59B | |
-1.85% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.05% | 26.21B | |
-21.96% | 19.09B | |
+4.21% | 13.08B | |
+25.74% | 12.26B | |
+27.42% | 12.05B |